Announcement of National Medical Products Administration and National Intellectual Property Administration on the Issuance of the Measures for the Implementation of the Mechanism for Early Settlement of Drug Patent Disputes (Interim)
In accordance with the Patent Law of the People's Republic of China, the National Medical Products Administration and the China National Intellectual Property Administration formulated the Measures for the Implementation of the Mechanism for Early Settlement of Drug Patent Disputes (interim), which will be promulgated and put into effect on July 4 with the approval by the State Council.
